RxDoctor Payments Data

Tzyy-Choou Wu, MD

Anatomic Pathology & Clinical Pathology · Baltimore, MDNPI 1427087972

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $290 of the $359 with a category attached, or 80.8%. Every reported general payment came from a single manufacturer, Sysmex America, Inc..

$359in general payments, 2019–2025

Across 4 payments — averaging $89.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sysmex America, Inc.$359
$339,000in research payments, 2019–2025

Across 1 payment — averaging $339,000 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AbbVie$339K

What the payments were for

  • Food & beverage$29081%
  • Gifts$6919%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Sysmex America, Inc.4$359

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$359 in reported general payments places this provider in the 70th percentile of 186 anatomic pathology & clinical pathology providers in Maryland.

See all anatomic pathology & clinical pathology providers in Maryland

Medicare billing

Part B allowed, 2024
$2,369
Medicare patients
18
Services billed
56

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other anatomic pathology & clinical pathology in Baltimore

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →